ZA928290B - Triazaspirodecanone-methylchromans. - Google Patents

Triazaspirodecanone-methylchromans.

Info

Publication number
ZA928290B
ZA928290B ZA928290A ZA928290A ZA928290B ZA 928290 B ZA928290 B ZA 928290B ZA 928290 A ZA928290 A ZA 928290A ZA 928290 A ZA928290 A ZA 928290A ZA 928290 B ZA928290 B ZA 928290B
Authority
ZA
South Africa
Prior art keywords
methylchromans
medicaments
triazaspirodecanone
triazaspirodecanones
triazaspirodecanonemethylchromans
Prior art date
Application number
ZA928290A
Other languages
English (en)
Inventor
Hans-Georg Heine
Rudolf Schohe-Loop
Thomas Glaser
Jean Marie Viktor De Vry
Wolfgang Dompert
Henning Sommermeyer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA928290B publication Critical patent/ZA928290B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA928290A 1991-10-28 1992-10-27 Triazaspirodecanone-methylchromans. ZA928290B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4135473A DE4135473A1 (de) 1991-10-28 1991-10-28 Triazaspirodecanon-methylchromane

Publications (1)

Publication Number Publication Date
ZA928290B true ZA928290B (en) 1993-05-04

Family

ID=6443565

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA928290A ZA928290B (en) 1991-10-28 1992-10-27 Triazaspirodecanone-methylchromans.

Country Status (19)

Country Link
US (1) US6060482A (enExample)
EP (1) EP0539803B1 (enExample)
JP (1) JP3257708B2 (enExample)
KR (1) KR930007945A (enExample)
AT (1) ATE175414T1 (enExample)
AU (1) AU650792B2 (enExample)
CA (1) CA2081256A1 (enExample)
CZ (1) CZ322492A3 (enExample)
DE (2) DE4135473A1 (enExample)
DK (1) DK0539803T3 (enExample)
ES (1) ES2125879T3 (enExample)
FI (1) FI924848A7 (enExample)
GR (1) GR3029450T3 (enExample)
HU (1) HUT64068A (enExample)
IL (1) IL103546A0 (enExample)
MX (1) MX9205869A (enExample)
NO (1) NO923974L (enExample)
TW (1) TW208010B (enExample)
ZA (1) ZA928290B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19522088A1 (de) * 1995-06-19 1997-01-02 Bayer Ag Benzisothiazolyl-substituierte Aminomethylchromane
CA2226058C (en) * 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives
US6686370B2 (en) * 1999-12-06 2004-02-03 Euro-Celtique S.A. Triazospiro compounds having nociceptin receptor affinity
WO2003040382A1 (en) * 2001-11-09 2003-05-15 Kaneka Corporation Process for producing optically active chroman derivative and intermediate
US6995168B2 (en) 2002-05-31 2006-02-07 Euro-Celtique S.A. Triazaspiro compounds useful for treating or preventing pain
AU2003268512A1 (en) * 2002-09-09 2004-03-29 Janssen Pharmaceutica N.V. Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
US20070229303A1 (en) * 2003-10-16 2007-10-04 Collier Willliam R Fluid Level Detector and Alarm Apparatus
US20060178390A1 (en) * 2004-08-02 2006-08-10 Alfonzo Jordan 1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
CN101622254B (zh) * 2006-11-28 2013-05-29 詹森药业有限公司 3-(3-氨基-2-(r)-羟基-丙基)-1-(4-氟-苯基)-8-(8-甲基-萘-1-基甲基)-1,3,8-三氮杂-螺[4.5]癸烷-4-酮的盐
MX2009011006A (es) * 2007-04-09 2009-11-02 Janssen Pharmaceutica Nv Derivados de 1,3,8-trisustituido-1,3,8-triaza-espiro[4.5]decano-4- ona como ligandos del receptor de orl-1 para el tratamiento de ansiedad y depresion.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826835A (en) * 1971-01-08 1974-07-30 Ciba Geigy Corp 8-benzofurylmethyl-1,3,8-triazaspiro(4,5)decanes as neuroleptics
US4749702A (en) * 1985-04-15 1988-06-07 Janssen Pharmaceutica N. V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4689330A (en) * 1985-04-15 1987-08-25 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4826848A (en) * 1985-04-15 1989-05-02 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4957928A (en) * 1986-06-26 1990-09-18 Ciba-Geigy Corporation Hydrogenated 1-benzooxacycloalkylpyridinecarboxylic acid compounds
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
DE3831888A1 (de) * 1988-09-20 1990-03-29 Troponwerke Gmbh & Co Kg Arzneimittel zur behandlung von apoplexia cerebri
DE4039631A1 (de) * 1990-12-12 1992-06-17 Troponwerke Gmbh & Co Kg Neuroprotektive kombination

Also Published As

Publication number Publication date
US6060482A (en) 2000-05-09
KR930007945A (ko) 1993-05-20
GR3029450T3 (en) 1999-05-28
AU2626592A (en) 1993-04-29
ES2125879T3 (es) 1999-03-16
MX9205869A (es) 1993-04-01
CA2081256A1 (en) 1993-04-29
HUT64068A (en) 1993-11-29
FI924848A0 (fi) 1992-10-26
NO923974L (no) 1993-04-29
NO923974D0 (no) 1992-10-13
EP0539803A1 (de) 1993-05-05
JP3257708B2 (ja) 2002-02-18
DE4135473A1 (de) 1993-04-29
EP0539803B1 (de) 1999-01-07
DE59209607D1 (de) 1999-02-18
FI924848A7 (fi) 1993-04-29
HU9203382D0 (en) 1993-01-28
CZ322492A3 (en) 1993-07-14
JPH05222040A (ja) 1993-08-31
DK0539803T3 (da) 1999-08-30
AU650792B2 (en) 1994-06-30
ATE175414T1 (de) 1999-01-15
TW208010B (enExample) 1993-06-21
IL103546A0 (en) 1993-03-15

Similar Documents

Publication Publication Date Title
FI925549A0 (fi) Nya azaheterocyklylmetyl-kromaner
FR2672818B1 (fr) Procede de production d'oxygene par adsorption.
IL109578A (en) Nor-bile acid derivatives processes for their preparation and the use of these compounds as medicaments
AU2294788A (en) Apparatus for the intensive, controlled production of microorganisms by photosynthesis
ZA928643B (en) The resolution of 5-methyltetrahydrofolic acid
ZA925128B (en) Pyrrolidine derivatives,their preparation and medicaments containing them
FI91068C (fi) Menetelmä diorganodialkoksisilaanien valmistamiseksi
TW208010B (enExample)
ES2023509B3 (es) Producto granular (i).
ATE155478T1 (de) 4,13-dioxabicyclo(8.2.1>tridecenon-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ES2000368A6 (es) Un procedimiento para preparar di-t-butilfenoles sustituidos
GR3018679T3 (en) Preparation of substituted piperidines.
EP0486386A3 (en) Novel derivatives of n-benzoylproline, process for their preparation and drugs containing them
EP0224842A3 (en) Pyrazolesulfonamide derivative, process for its production and herbicide containing it
ITRM920153U1 (it) Crociera centrale per treppiede.
NZ248794A (en) 3-carboxy-(and phosphonoxy-)alkatriene-substituted chromene derivatives and medicaments
ITMI920460A0 (it) Procedimento per produrre l-lisina mediante fermentazione
ZA932359B (en) 3-Aminochroman spiro compounds processes for preparing them and pharmaceutical compositions containing them
AU648924B2 (en) New 1-(alkoxybenzyl)piperazine amide compounds, processes for preparing them and pharmaceutical compositions containing them
DE3881866D1 (de) System zur belichtungsadressierung hoher aufloesung mit grobaufgeloestem belichtungsfeld.
DE68906049D1 (de) Benzocyclohexan- und benzocycloheptan-derivate und deren salze, verfahren und zwischenprodukte zu deren herstellung, deren verwendung als heilmittel und diese enthaltende zusammensetzungen.
ES2124335T3 (es) Sistema de alimentacion de vidrio por orificios multiples empleando nucleos moviles.
DE3851979D1 (de) Substituierte Vinylcephalosporine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
NO865179D0 (no) Fremgangsmaate for fremstilling av 2-klor-12-(3-dimethylamino-2-methylpropyl)-12h-dibenzo(d,g)(1,3,6)dioxazociner.
PT746556E (pt) Compostos triciclicos com afinidade para o receptor 5-ht1a